Subscribe

Suraksha Diagnostic Ltd. (SURAKSHA.NS)

INR261.40 +1.45 (+0.56%)
IN NSE Healthcare Medical - Care Facilities
Address Plot No. DG- 12/1 700156
Kolkata, MH, IN
CEO Ritu Mittal
Website surakshanet.com
IPO 2024-12-06
ISIN INE877V01027

Explore sections of this company profile

Also trades on Bombay Stock Exchange · SURAKSHA.BO (INR) National Stock Exchange of India · SURAKSHA.NS (INR)
Description

Suraksha Diagnostic Limited operates a chain of diagnostic centers in India. It offers pathology testing services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, and haematology; genomics testing, including microarray, noninvasive prenatal, quantitative fluorescent polymerase chain reaction, fluorescence in situ hybridization, and karyotyping; and radiology testing that includes X ray, magnetic resonance imaging, computed tomography scan, USG, DEXA scan, OPG, and mammography. The company also provides Cardiology testing services comprises electrocardiogram, echocardiogram, stress test / treadmill test, wireless holter monitoring, colour doppler, peripheral doppler, and pulmonary function test; gastroenterology, such as upper and lower GI endoscopy, sigmoidoscopy, proctoscopy, colonoscopy, and proctosigmoidoscopy; and neurology testing services, including electroencephalogram, electromyography, and nerve conduction velocity test. In addition, the company provides dental, physiotherapy, immunology & rheumatology, eye, fetal care, ENT, and speciality clinics, as well as home doctor visit services. The company was founded in 1992 and is based in Kolkata, India.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
INR261.40 +1.45 (+0.56%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
37.5K
Beta
1.68
Float Shares
26.62M
Free Float %
51.1%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-1.86% -9.40% +2.38% +6.83% -0.92% +7.55% -13.70% -30.61% -30.61% -30.61% -30.61%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
261.40
DCF (Unlevered) 81.30 -68.9%
DCF (Levered) 70.49 -73.0%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 0% Bullish
Rating 2026-05 Change
Strong Buy 0 0
Buy 0 0
Hold 1 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
5.55
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
5 / 10
Developing
Composite Rating
B
Overall Score
3 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
  • ✓
    Revenue growth Medical - Care Facilities: +10.2%
    +23.1% ★ Q1'26: +25.1% (vs Q1'25)
  • ✓
    EPS growth Medical - Care Facilities: +19.2%
    +3.5% Q1'26: -14.8% (vs Q1'25)
  • ✓
    FCF margin FCF growth · Medical - Care Facilities: +32.0%
    +8.6% Q1'26: +16.3% (vs Q1'25)
  • ✗
    EBIT margin Medical - Care Facilities: +11.3%
    +17.5% ★ Q1'26: +16.5% (vs Q1'25)
  • ✗
    ROIC Medical - Care Facilities: +6.8%
    +11.0% ★ Q1'26: +9.5% (vs Q1'25)
  • ✓
    Share dilution Medical - Care Facilities: +0.0%
    -2.3% ★ Q1'26: -1.5% (vs Q1'25)
  • ✓
    Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×
    1.36× Q1'26: 1.32× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (1.74) × ERP
WACC = 92% × Ke + 8% × Kd (9.6%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 81.50 Current price: 261.40
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Mar 2025
actual 		Mar 2026
1 Rev. Ana.
1 EPS Ana. 		Mar 2027
1 Rev. Ana.
1 EPS Ana. 		Mar 2028
1 Rev. Ana.
1 EPS Ana. 		Mar 2029
1 Rev. Ana.
1 EPS Ana. 		Mar 2030
1 Rev. Ana.
1 EPS Ana.
Revenue
2.52B
est: 2.53B (-0.2%)
2.97B
2.97B – 2.97B
+17.7% YoY
3.35B
3.35B – 3.35B
+12.7% YoY
3.86B
3.86B – 3.86B
+15.3% YoY
5.04B
5.04B – 5.04B
+30.3% YoY
5.76B
5.76B – 5.76B
+14.4% YoY
EBITDA
850.88M
est: 768.79M (+10.7%)
904.51M
904.51M – 904.51M
+17.7% YoY
1.02B
1.02B – 1.02B
+12.7% YoY
1.18B
1.18B – 1.18B
+15.3% YoY
1.53B
1.53B – 1.53B
+30.3% YoY
1.75B
1.75B – 1.75B
+14.4% YoY
EBIT
497.91M
est: 406.80M (+22.4%)
478.62M
478.62M – 478.62M
+17.7% YoY
539.56M
539.56M – 539.56M
+12.7% YoY
622.16M
622.16M – 622.16M
+15.3% YoY
810.71M
810.71M – 810.71M
+30.3% YoY
927.61M
927.61M – 927.61M
+14.4% YoY
Net Income
318.24M
est: 322.91M (-1.4%)
333.33M
333.33M – 333.33M
+3.2% YoY
401.04M
401.04M – 401.04M
+20.3% YoY
479.16M
479.16M – 479.16M
+19.5% YoY
812.49M
812.49M – 812.49M
+69.6% YoY
1.10B
1.10B – 1.10B
+35.9% YoY
SGA
502.31M
est: 548.33M (-8.4%)
645.13M
645.13M – 645.13M
+17.7% YoY
727.28M
727.28M – 727.28M
+12.7% YoY
838.61M
838.61M – 838.61M
+15.3% YoY
1.09B
1.09B – 1.09B
+30.3% YoY
1.25B
1.25B – 1.25B
+14.4% YoY
EPS
6.11
est: 6.20 (-1.5%)
6.40
6.40 – 6.40
+3.2% YoY
7.70
7.70 – 7.70
+20.3% YoY
9.20
9.20 – 9.20
+19.5% YoY
15.60
15.60 – 15.60
+69.6% YoY
21.20
21.20 – 21.20
+35.9% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-27 B 3/5 3/5 4/5 5/5 2/5 1/5 2/5
2026-05-26 B 3/5 3/5 4/5 5/5 2/5 1/5 2/5
2026-05-25 B 3/5 3/5 4/5 5/5 2/5 1/5 2/5
2026-05-22 B 3/5 3/5 4/5 5/5 2/5 1/5 2/5
2026-05-21 C- 1/5 3/5 1/5 1/5 1/5 1/5 1/5
2026-05-20 C- 1/5 3/5 1/5 1/5 1/5 1/5 1/5
2026-05-19 C- 1/5 3/5 1/5 1/5 1/5 1/5 1/5
2026-05-18 C- 1/5 3/5 1/5 1/5 1/5 1/5 1/5
2026-05-15 C- 1/5 3/5 1/5 1/5 1/5 1/5 1/5
2026-05-14 C- 1/5 3/5 1/5 1/5 1/5 1/5 1/5
2026-05-13 C- 1/5 3/5 1/5 1/5 1/5 1/5 1/5
2026-05-12 C- 1/5 3/5 1/5 1/5 1/5 1/5 1/5
2026-05-11 C- 1/5 3/5 1/5 1/5 1/5 1/5 1/5
2026-05-08 C- 1/5 3/5 1/5 1/5 1/5 1/5 1/5
2026-05-07 C- 1/5 3/5 1/5 1/5 1/5 1/5 1/5
2026-05-06 C- 1/5 3/5 1/5 1/5 1/5 1/5 1/5
2026-05-05 C- 1/5 3/5 1/5 1/5 1/5 2/5 1/5
2026-05-04 C- 1/5 3/5 1/5 1/5 1/5 2/5 1/5
2026-04-30 C- 1/5 3/5 1/5 1/5 1/5 2/5 1/5
2026-04-29 C- 1/5 3/5 1/5 1/5 1/5 2/5 1/5
2026-04-28 C- 1/5 3/5 1/5 1/5 1/5 2/5 1/5
2026-04-27 C- 1/5 3/5 1/5 1/5 1/5 2/5 1/5
2026-04-24 C- 1/5 3/5 1/5 1/5 1/5 2/5 1/5
2026-04-23 C- 1/5 3/5 1/5 1/5 1/5 1/5 1/5
2026-04-22 C- 1/5 3/5 1/5 1/5 1/5 1/5 1/5
2026-04-21 C- 1/5 3/5 1/5 1/5 1/5 1/5 1/5
2026-04-20 C- 1/5 3/5 1/5 1/5 1/5 1/5 1/5
2026-04-17 C- 1/5 3/5 1/5 1/5 1/5 1/5 1/5
2026-04-16 C- 1/5 3/5 1/5 1/5 1/5 1/5 1/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
454.26M
OE per share TTM
8.72
Owner's Yield
3.02%
Maintenance CapEx ratio
123.30%
Maint CapEx / Avg PPE
97.7%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
418.6K
Shares Outstanding
52.08M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Ritu Mittal Joint MD, Chief Executive Officer & Executive Director 22M female
Somnath Chatterjee Executive Chairman & Joint MD 22M —
Niren Kaul Chief Sales Operations — male
Balgopal Jhunjhunwala Regional Business Head — male
Sangeeta Chakraborty General Manager of Operations — female
Ravindra K. S. Chief Financial Officer — male
Mamta Jain Company Secretary & Compliance Officer — female
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Care Facilities